Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Market Cap	28.07B
Revenue (ttm)	5.29B
Net Income (ttm)	9.61M
Shares Out	13.83B
EPS (ttm)	0.00
PE Ratio	2,921.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,324,620
Average Volume	254,616,311
Open	2.030
Previous Close	2.030
Day's Range	2.020 - 2.050
52-Week Range	1.680 - 2.950
Beta	0.63
RSI	46.12
Earnings Date	Aug 30, 2025

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 4,233
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600518

Financial Performance

In 2024, Kangmei Pharmaceutical's revenue was 5.19 billion, an increase of 6.47% compared to the previous year's 4.87 billion. Earnings were 8.57 million, a decrease of -91.64%.